Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Practical Microenvironment Classification in Diffuse Large B-Cell Lymphoma Using Digital Pathology

Yuqing Wang, Shuo Wang, Hongmei Yi, Yue Wang, Haimin Xu, Shuang Tian, Yan Dong, Jing Zhao, Di Fu, Rongji Mu, Shuye Wang, Li Wang, Pengpeng Xu, Wei Li Zhao

Blood (2024) 144 (Supplement 1): 4974.

https://doi.org/10.1182/blood-2024-202864

Published: 2024

Journal Articles

Part a Efficacy and Safety of Oral Bruton Tyrosine Kinase Inhibitor (BTKi) Rilzabrutinib in Patients with Warm Autoimmune Hemolytic Anemia (wAIHA): Multicenter, Open-Label, Phase 2b Study

Nichola Cooper, David J Kuter, Henrik Frederiksen, Bing Han, Frederick Chen, Wilma Barcellini, Joan Cid, Catherine M. Broome, Míriam Vara, Amitabha Mazumder, Alessandro Lucchesi, Xin Zhao, Antonio M Risitano, Sumit Sawhney, Quentin A. Hill, Deepthi Jayawardene, Remco Diab, Jing Zhao, Ahmed Daak

Blood (2024) 144 (Supplement 1): 3836.

https://doi.org/10.1182/blood-2024-200325

Published: 2024

Journal Articles

C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up

Blood (2023) 142 (Supplement 1): 1025.

https://doi.org/10.1182/blood-2023-182817

Published: 2023

Journal Articles

Association of Hemoglobin Levels with Healthcare Resource Utilization and Costs in Non-Transfusion-Dependent α- and β-Thalassemia: A Retrospective Observational Study Using Real-World Data

Arielle L Langer, Amey Rane, Louise Lombard, Keely S Gilroy, Junlong Li, Jing Zhao, Carolyn R Lew, Brian M Davis, Ryan Ross, Sujit Sheth

Blood (2023) 142 (Supplement 1): 5244.

https://doi.org/10.1182/blood-2023-189236

Published: 2023

Journal Articles

Mitapivat Treatment Reduces Levels of Interference in Work/School Activity for Adult Patients with Pyruvate Kinase Deficiency

Jennifer A Rothman, Parija Patel, Jing Zhao, Susan Morris, Junlong Li, Hanny Al-Samkari

Blood (2023) 142 (Supplement 1): 2365.

https://doi.org/10.1182/blood-2023-180697

Published: 2023

Journal Articles

Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study

Jan P. Nicolay, Susanne Melchers, Jana D. Albrecht, Chalid Assaf, Edgar Dippel, Rudolf Stadler, Ulrike Wehkamp, Marion Wobser, Jing Zhao, Ina Burghaus, Sven Schneider, Karsten Gülow, Sergij Goerdt, Christian M. Schürch, Jochen S. Utikal, Peter H. Krammer

Blood (2023) 142 (9): 794–805.

https://doi.org/10.1182/blood.2022018669

Published: 2023

Includes: Supplemental data

Journal Articles

Clinical Burden of Alpha- and Beta-Thalassemia Compared to Matched Controls in the Real-World Setting

Arielle L. Langer, Louise Lombard, Keely Gilroy, Junlong Li, Jing Zhao, Carolyn R. Lew, Erin Bullock, Brian M Davis, Sujit Sheth

Blood (2022) 140 (Supplement 1): 5362–5364.

https://doi.org/10.1182/blood-2022-167265

Published: 2022

Journal Articles

PD-1 Inhibitors Can be the First-Line Therapy for Myelodysplastic Syndrome (MDS) --Study on the Bone Marrow Immune Microenvironment of MDS By Multispectral Imaging of Multiplex Immunofluorescence

Minghua Hong, Ying Xie, Jing Zhao, Ting Lu, Jie Sun, He Huang

Blood (2022) 140 (Supplement 1): 12303–12304.

https://doi.org/10.1182/blood-2022-166782

Published: 2022

Journal Articles

Cancer and Treatment Distress (CTXD) and Confidence in Survivorship Information (CSI) Trends in Older (≥60 Years) Allogeneic Hematopoietic Cell Transplantation (AlloHCT) Survivors

Sanghee Hong, Jing Zhao, Ji-Hyun Lee, Nosha Farhadfar, Jean C. Yi, Jaime M. Preussler, K. Scott Baker, Bronwen E. Shaw, Steven Devine, Karen Syrjala, John R. Wingard, Navneet S. Majhail, Zeina Al-Mansour

Blood (2021) 138 (Supplement 1): 4123.

https://doi.org/10.1182/blood-2021-145428

Published: 2021

Journal Articles

Distress, Health-Related Quality of Life (HQOL) and Confidence in Survivorship Information (CSI) in Older (≥60 Years) Hematopoietic Cell Transplant (HCT) Patients

Zeina Al-Mansour, Sanghee Hong, Nosha Farhadfar, Jing Zhao, Ji-Hyun Lee, Bronwen E. Shaw, Steven Devine, Jean C. Yi, Jaime M. Preussler, K. Scott Baker, Karen Syrjala, Navneet S. Majhail, John R. Wingard

Blood (2021) 138 (Supplement 1): 426.

https://doi.org/10.1182/blood-2021-151037

Published: 2021

Journal Articles

Patient Preferences for Hemophilia a Treatments: A Discrete Choice Experiment

Shawn X. Sun, Jing Zhao, Hongbo Yang, PhD, Eric Wu

Blood (2020) 136 (Supplement 1): 22.

https://doi.org/10.1182/blood-2020-134656

Published: 2020

Journal Articles

Human Interleukin 15 (IL15) Humanized NCG Mice Support the Human Natural Killer Cells Reconstitution and Development

Cunxiang Ju, PhD, Mingkun Zhang, Dan Wu, Jing Tang, PhD, Shuai Li, Jing Zhao, PhD, Demin Wang, PhD, Xiang Gao, PhD

Blood (2019) 134 (Supplement_1): 4871.

https://doi.org/10.1182/blood-2019-123661

Published: 2019

Journal Articles

BALB/c-hCD3E Transgenic Mice: An Ideal Animal Model for In Vivo Efficacy Study of CD3-Bispecific Antibodies

Cunxiang Ju, PhD, Mingkun Zhang, Dongjing Jia, Jing Tang, PhD, Shuai Li, Jing Zhao, PhD, Demin Wang, PhD, Xiang Gao, PhD

Blood (2019) 134 (Supplement_1): 1048.

https://doi.org/10.1182/blood-2019-128781

Published: 2019

Journal Articles

Low-dose chidamide restores immune tolerance in ITP in mice and humans

Hong-yu Zhao, Ya-hui Ma, Da-qi Li, Tao Sun, Li-zhen Li, Ping Li, Xin-guang Liu, Hai Zhou, Yu Hou, Yang Liu, Pan-pan Han, Ya-jing Zhao, Fang-miao Jing, Jun Peng, Ming Hou

Blood (2019) 133 (7): 730–742.

https://doi.org/10.1182/blood-2018-05-847624

Published: 2019

Includes: Supplemental data

NARROW

Practical Microenvironment Classification in Diffuse Large B-Cell Lymphoma Using Digital Pathology

Part a Efficacy and Safety of Oral Bruton Tyrosine Kinase Inhibitor (BTKi) Rilzabrutinib in Patients with Warm Autoimmune Hemolytic Anemia (wAIHA): Multicenter, Open-Label, Phase 2b Study

C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up

Association of Hemoglobin Levels with Healthcare Resource Utilization and Costs in Non-Transfusion-Dependent α- and β-Thalassemia: A Retrospective Observational Study Using Real-World Data

Mitapivat Treatment Reduces Levels of Interference in Work/School Activity for Adult Patients with Pyruvate Kinase Deficiency

Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study

Clinical Burden of Alpha- and Beta-Thalassemia Compared to Matched Controls in the Real-World Setting

PD-1 Inhibitors Can be the First-Line Therapy for Myelodysplastic Syndrome (MDS) --Study on the Bone Marrow Immune Microenvironment of MDS By Multispectral Imaging of Multiplex Immunofluorescence

Cancer and Treatment Distress (CTXD) and Confidence in Survivorship Information (CSI) Trends in Older (≥60 Years) Allogeneic Hematopoietic Cell Transplantation (AlloHCT) Survivors

Distress, Health-Related Quality of Life (HQOL) and Confidence in Survivorship Information (CSI) in Older (≥60 Years) Hematopoietic Cell Transplant (HCT) Patients

Patient Preferences for Hemophilia a Treatments: A Discrete Choice Experiment

Human Interleukin 15 (IL15) Humanized NCG Mice Support the Human Natural Killer Cells Reconstitution and Development

BALB/c-hCD3E Transgenic Mice: An Ideal Animal Model for In Vivo Efficacy Study of CD3-Bispecific Antibodies

Low-dose chidamide restores immune tolerance in ITP in mice and humans

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only